WORST OF BARRIER REVERSE CONVERTIBLE LINKED TO WORST OF - ROCHE GS/MODERNA/ZUR ROSE Share Price

Certificat

KMDXDU

CH1196849900

Market Closed - Swiss Exchange 16:20:00 10/05/2024 BST
69.05 CHF +0.58% Intraday chart for WORST OF BARRIER REVERSE CONVERTIBLE LINKED TO WORST OF - ROCHE GS/MODERNA/ZUR ROSE
Current month+3.68%
1 month+3.14%
Date Price Change Volume
10/05/24 69.05 +0.58% 0
08/05/24 68.65 +0.07% 0
07/05/24 68.6 +0.88% 0
03/05/24 68 +1.95% 0

Delayed Quote Swiss Exchange

Last update May 10, 2024 at 04:20 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
KMDXDU
ISINCH1196849900
Date issued 06/07/2022
Strike 323.4 CHF
Maturity 08/07/2024 (57 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 99.85 CHF
Lowest since issue 50.05 CHF
Spread 10 CHF
Spread %1.43%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.12%
Consensus
  1. Stock Market
  2. Certificates
  3. KMDXDU Certificat